EuroInf: A multicenter comparative observational study of apomorphine and levodopa infusion in Parkinson's disease

Movement Disorders

Volumn 30, Issue 4, 2015, Pages 510-516

  Martinez Martin, Pablo ^a   Reddy, Prashanth ^b   Katzenschlager, Regina ^c   Antonini, Angelo ^d   Todorova, Antoniya ^b   Odin, Per ^e   Henriksen, Tove ^f   Martin, Anne ^b   Calandrella, Daniela ^d   Rizos, Alexandra ^b   Bryndum, Narissah ^f   Glad, Arne ^f   Dafsari, Haidar Salimi ^g   Timmermann, Lars ^g   Ebersbach, Georg ^h   Kramberger, Milica G ⁱ   Samuel, Michael ^b   Wenzel, Karoline ^j   Tomantschger, Volker ^k   Storch, Alexander ^l   Reichmann, Heinz ^l   Pirtosek, Zvezdan ⁱ   Trost, Maja ⁱ   Svenningsson, Per ^m   Palhagen, Sven ^m   Volkmann, Jens ⁿ   Chaudhuri, K Ray ^b   more..

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c DANUBE HOSPITAL   (Austria)

^d IRCCS SAN CAMILLO HOSPITAL   (Italy)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f BISPEBJERG HOSPITAL   (Denmark)

^g UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

^h Movement Disorder Clinic   (Germany)

ⁱ UNIVERSITY MEDICAL CENTRE LJUBLJANA   (Slovenia)

^j MEDICAL UNIVERSITY OF GRAZ   (Austria)

^k Gailtal Klinik Hermagor   (Austria)

^l DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

more..

Author keywords

Apomorphine infusion; Intrajejunal levodopa infusion; Nonmotor symptoms; Parkinson's disease; Quality of life

Indexed keywords

AMANTADINE; APOMORPHINE; CATECHOL METHYLTRANSFERASE INHIBITOR; DECARBOXYLASE INHIBITOR; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; ROTIGOTINE;

ADULT; AGED; ANXIETY; APATHY; ARTICLE; ATTENTION; BLOATING; COMPARATIVE STUDY; DRUG INDUCED DISEASE; EVENING DOSAGE; FATIGUE; FEMALE; GASTROINTESTINAL TRACT FUNCTION; HALLUCINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY; MOOD; MULTICENTER STUDY; NEUROLOGIC DISEASE; NON MOTOR SYMPTOM SCALE; NONMOTOR SYMPTOM; OBSERVATIONAL STUDY; OPEN STUDY; PAIN; PARKINSON DISEASE; PERITONITIS; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RATING SCALE; SEXUALITY; SKIN NODULE; SLEEP; SLEEP DISORDER; SOMNOLENCE; STOMA SITE IRRITATION; URINARY TRACT FUNCTION;

EID: 84964241167     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.26067     Document Type: Article

References (33)

1. Chinthapalli K. NICE is dead; long live NICE. BMJ 2013;346:f2546.
2. Dodel R, Jönsson B, Reese JP, et al. Measurement of costs and scales for outcome evaluation in health economic studies of Parkinson's disease. Mov Disord 2014;29:169-176.
3. Olanow CW, Kieburtz K, Odin P, et al. Continuous intrajejunal infusion of levodopa-carbidopa intestinal gel for patients with advanced Parkinson's disease: a randomised, controlled, double-blind, double-dummy study. Lancet Neurol 2014;13:141-149.
4. Chaudhuri KR, Odin P. The challenge of non-motor symptoms in Parkinson's disease. Prog Brain Res 2010;184:325-341.
5. Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical E. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006;5:235-245.
6. Lees AJ, Hardy J, Revesz T. Parkinson's disease. Lancet 2009;373:2055-2066.
7. Goetz CG, Poewe W, Rascol O, et al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord 2004;19:1020-1028.
8. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurology 1967;17:427-442.
9. Fahn S, Elton RL, and members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Development in Parkinson's Disease, Vol. 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-164.
10. Chaudhuri KR, Martinez-Martin P, Brown RG, et al. The metric properties of a novel non-motor symptoms scale for Parkinson's disease: results from an international pilot study. Mov Disord 2007;22:1901-1911.
11. Martinez-Martin P, Rodriguez-Blazquez C, Abe K, et al. International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease. Neurology 2009;73:1584-1591.
12. Jenkinson C, Fitzpatrick R, Peto V, Greenhall R, Hyman N. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age Ageing 1997;26:353-357.
13. Tomlinson CL, Stowe R, Patel S, Rick C, Gray R, Clarke CE. Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Mov Disord 2010;25:2649-2653.
14. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc B 1995;57:289-300.
15. Deyo RA, Centor RM. Assessing the responsiveness of functional scales to clinical change: an analogy to diagnostic test performance. J Chronic Dis 1986;39:897-906.
16. Cohen J. Statistical Power Analysis for the Behavioral Sciences. Academic; 1977:8.
17. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changes in health status. Med Care 1989;27(3 Suppl):S178-S189.
18. Sloan JA, Cella D, Hays RD. Clinical significance of patient-reported questionnaire data: another step toward consensus. J Clin Epidemiol 2005;58:1217-1219.
19. Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003;41:582-592.
20. Wyrwich KW, Norquist JM, Lenderking WR, Acaster S; Industry Advisory Committee of International Society for Quality of Life R. Methods for interpreting change over time in patient-reported outcome measures. Qual Life Res 2013;22:475-483.
21. Martinez-Martin P, Reddy P, Antonini A, et al. Chronic subcutaneous infusion therapy with apomorphine in advanced Parkinson's disease compared to conventional therapy: a real life study of non motor effect. J Parkinsons Dis 2011;1:197-203.
22. Reddy P, Martinez-Martin P, Rizos A, et al. Intrajejunal levodopa versus conventional therapy in Parkinson disease: motor and nonmotor effects. Clin Neuropharmacol 2012;35:205-207.
23. Storch A, Schneider CB, Wolz M, et al. Nonmotor fluctuations in Parkinson disease: severity and correlation with motor complications. Neurology 2013;80:800-809.
24. Chaudhuri KR, Schapira AH. Non-motor symptoms of Parkinson's disease: dopaminergic pathophysiology and treatment. Lancet Neurol 2009;8:464-474.
25. Ellis C, Lemmens G, Parkes JD, et al. Use of apomorphine in parkinsonian patients with neuropsychiatric complications to oral treatment. Parkinsonism Relat Disord 1997;3:103-107.
26. Wollman B, D'Agostino HB, Walus-Wigle JR, Easter DW, Beale A. Radiologic, endoscopic, and surgical gastrostomy: an institutional evaluation and meta-analysis of the literature. Radiology 1995;197:699-704.
27. Klostermann F, Jugel C, Bomelburg M, Marzinzik F, Ebersbach G, Muller T. Severe gastrointestinal complications in patients with levodopa/carbidopa intestinal gel infusion. Mov Disord 2012;27:1704-1705.
28. Santos-Garcia D, de la Fuente-Fernandez R, Valldeoriola F, et al. Polyneuropathy while on duodenal levodopa infusion in Parkinson's disease patients: we must be alert. J Neurol 2012;259:1668-1672.
29. Urban PP, Wellach I, Faiss S, Layer P, Rosenkranz T, Knop K, Weis J. Subacute axonal neuropathy in Parkinson's disease with cobalamin and vitamin B6 deficiency under duodopa therapy. Mov Disord 2010;25:1748-1752.
30. Muller T, van Laar T, Cornblath DR, et al. Peripheral neuropathy in Parkinson's disease: levodopa exposure and implications for duodenal delivery. Parkinsonism Relat Disord 2013;19:501-507.
31. Bliwise DL, Trotti LM, Juncos JJ, Factor SA, Freeman A, Rye DB. Daytime REM sleep in Parkinson's disease. Parkinsonism Relat Disord 2013;19:101-103.
32. Weintraub D, Koester J, Potenza MN, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol 2010;67:589-595.
33. Cilia R, Siri C, Canesi M, et al. Dopamine dysregulation syndrome in Parkinson's disease: from clinical and neuropsychological characterisation to management and long-term outcome. J Neurol Neurosurg Psychiatry 2014;85:311-318.